Winton Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Buy
+74,936
New +$1.75M 0.06% 307
2020
Q3
Sell
-25,773
Closed -$757K 1471
2020
Q2
$757K Buy
25,773
+7,715
+43% +$223K 0.02% 1077
2020
Q1
$486K Buy
+18,058
New +$539K 0.01% 1040
2018
Q4
Sell
-161,191
Closed -$11M 865
2018
Q3
$11M Buy
+161,191
New +$10.4M 0.23% 177
2017
Q1
Sell
-31,922
Closed -$1.18M 431
2016
Q4
$1.18M Buy
+31,922
New +$1.14M 0.04% 310

Other funds holding AVNS

Winton Group's AVNS Position: Q2 2026 in Review

Winton Group opened a new position in Avanos Medical (AVNS) in Q2 2026: 74,936 shares worth $1.86M. The stake represents 0.06% of the portfolio and ranks #307 among its holdings. This is a return to the name: Winton Group previously reported a position in AVNS as recently as Q2 2020.

Winton Group first reported a position in AVNS in Q4 2016 and has held it in 5 quarters since. The position peaked at $11M in Q3 2018. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Winton Group held 74,936 shares of Avanos Medical worth $1.86M as of Q2 2026.
  • Avanos Medical was a new Winton Group position in Q2 2026.
  • Avanos Medical made up 0.06% of Winton Group's portfolio in Q2 2026, its #307 holding.
  • Winton Group first reported a position in Avanos Medical in Q4 2016 and has held it in 5 quarters since.
  • Winton Group's Avanos Medical position peaked at $11M in Q3 2018.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.